研究制剂相对生物利用度的方法一般是,比较标准制剂(S)与试验制剂(T)的血药浓度-时间曲线下的总面积(AUC)。在一定间隔期同一受试者或同一组受试者交叉服用相同剂量的不同制剂,AUC与剂量之间为 The relative bioavailability of a formulation is generally determined by comparing the total area under the plasma concentration-time curve (AUC) of the standard formulation (S) to the test formulation (T). At regular intervals, the same subject or group of subjects were crossed with the same dose of different formulations, with a dose between AUC